Cargando…
Correlation of Circulating CD133+ Progenitor Subclasses with a Mild Phenotype in Duchenne Muscular Dystrophy Patients
BACKGROUND: Various prognostic serum and cellular markers have been identified for many diseases, such as cardiovascular diseases and tumor pathologies. Here we assessed whether the levels of certain stem cells may predict the progression of Duchenne muscular dystrophy (DMD). METHODS AND FINDINGS: T...
Autores principales: | Marchesi, Chiara, Belicchi, Marzia, Meregalli, Mirella, Farini, Andrea, Cattaneo, Alessandra, Parolini, Daniele, Gavina, Manuela, Porretti, Laura, D'Angelo, Maria Grazia, Bresolin, Nereo, Cossu, Giulio, Torrente, Yvan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377332/ https://www.ncbi.nlm.nih.gov/pubmed/18493616 http://dx.doi.org/10.1371/journal.pone.0002218 |
Ejemplares similares
-
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
por: Lerario, Alberto, et al.
Publicado: (2010) -
Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy
por: Bella, Pamela, et al.
Publicado: (2019) -
Preliminary Evidences of Safety and Efficacy of Flavonoids- and Omega 3-Based Compound for Muscular Dystrophies Treatment: A Randomized Double-Blind Placebo Controlled Pilot Clinical Trial
por: Sitzia, Clementina, et al.
Publicado: (2019) -
Influence of Immune Responses in Gene/Stem Cell Therapies for Muscular Dystrophies
por: Farini, Andrea, et al.
Publicado: (2014) -
The Immune System in Duchenne Muscular Dystrophy Pathogenesis
por: Tripodi, Luana, et al.
Publicado: (2021)